MEMOTEXT is honored that our patient adherence solutions have been selected as a finalist for the 3rd Annual Scattergood Foundation Innovation Award! This prestigious award recognizes innovation breakthroughs in the field of behavioral health-care.
The winners are leaders in their field who alter the paradigms of health-care delivery, have validated results, and the potential to benefit millions of patients. The award is jointly sponsored by the Thomas Scattergood Behavioral Health Foundation and The Kennedy Forum.
MEMOTEXT’s adherence solutions, in many way encapsulates what the Scattergood Award is all about. With over 100,000 deaths caused by poor medication adherence, MEMOTEXT is proud that its innovation can improve the lives of millions of patients. Realizing that adherence is caused by a multitude of individual factors, instead of forcing our patients into a one size fits all solution we created a solution that gives patients choice and adapts to their needs. Using our ‘Personalogic’ algorithms, MEMOTEXT nudges patients towards positive behavioral change, and adapts to changes in their lifestyle in real-time. Our evidence-based and validated methodology, shows that our programs achieve a 31.4% increase in medication adherence, retention rates of over 88%, and up to 55% increases in MPR (medication possession ratio).
Thank you all for your support!
With an MSc in the Theory and History of International Relations from the London School of Economics, Noah brings several years of communications experience to MEMOTEXT. Prior to joining, he worked for the Government of Ontario, several small businesses, and most recently on the winning campaign in the 2014 Toronto mayoral election. As someone who loves communicating good ideas to help make the world a better place, Noah is thrilled to be a part of the MEMOTEXT team.